Pacira BioSciences, Inc. — Director's Dealing 2012

Jan 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2012-01-03

Reporting Person: Pratt John (General Manager, San Diego)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-03	Employee Stock Option (right to buy)	$8.73	A	30000	Acquired	2022-01-02	Common Stock (30000)	Direct

Footnotes

F1: The stock option vests as follows: 25% of the shares shall vest on the one-year anniversary of the vesting commencement date, and the remaining shares vest 1/36th per month at the end of each successive month over the next three years.